Cell therapy weekly: Merck expands cell culture production capabilities

Published July 21, 2023

Print

RegMedNet reported Ruongang Zhao (BME) has received a $3 million grant from the National Institutes of Health to study a promising type of immunotherapy treatment for solid tumors.